04 September 2020 : Original article
Transplantation of a Novel Recombinant Adeno-Associated Virus (pAAV-HE1B19K-TE1A) Demonstrates Higher Anti-Tumor Effects in Tumor Cells
Zhuo-Qing Li1BCDEF, Hong Shen2BCDE, Kun-Xian Shu3BCDF, Jian-Jun Li1BCDF, Yin Tang4BCD, Jing-Jing Su4BCF, Jun Yan1BCD, Jie Yang3BCF, Ze-Qing Wang1BCF, Yan Qiu4BC, Yong Yang1CF, Yang Liu4CF, Yong Zhou5BDEG*DOI: 10.12659/AOT.925013
Ann Transplant 2020; 25:e925013

Figure 8 HE staining for analyzing pathological changes of vital organs of mice after pAAV-HE1B19K-TE1A injection and in the vital organs of normal mice. For the pAAV-HE1B19K-TE1A-injected mice, at 2 weeks after injection, the tissues (heart, liver, spleen, lung, and kidney) were collected for toxicity evaluation. Magnification, 400×.